America October 15, 2025
Novo Nordisk Inks $2.1B Licensing Deal for Rare Disease Breakthrough
In a bold move to deepen its footprint in rare disease treatment, Novo Nordisk SA announced Wednesday that it will…
America October 15, 2025
In a bold move to deepen its footprint in rare disease treatment, Novo Nordisk SA announced Wednesday that it will…
By Rihem Akkouche
America October 14, 2025
In a bold move that strengthens its foothold in the rare disease and immunology market, BioCryst Pharmaceuticals Inc. announced Tuesday…
By Rihem Akkouche
America March 14, 2024
AstraZeneca, a pharmaceutical giant, announced on Thursday its acquisition of Amolyt Pharma, a clinical stage biotechnology company, in a deal…
By Rihem Akkouche